{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:23:56Z","timestamp":1792873436579,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cyto.2020.154999","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T06:03:04Z","timestamp":1580450584000},"page":"154999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL\/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metformin"],"prefix":"10.1016","volume":"128","author":[{"given":"Thabsile J.","family":"Mahlangu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiwayinkosi V.","family":"Dludla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuyolwethu","family":"Mxinwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibusiso","family":"Mkandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe","family":"Mutize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawanda M.","family":"Nyambuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani B","family":"Nkambule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.154999_b0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diab. Res. Clin. Pract."},{"key":"10.1016\/j.cyto.2020.154999_b0010","doi-asserted-by":"crossref","unstructured":"G.S. Hotamisligil, Inflammation and metabolic disorders. Nature [Internet]. 444(7121) (2006) 860\u20137. Available from: https:\/\/doi.org\/10.1038\/nature05485.","DOI":"10.1038\/nature05485"},{"key":"10.1016\/j.cyto.2020.154999_b0015","first-page":"1922","article-title":"Metabolic regulation of immune responses Kirthana","volume":"1","author":"Castranova","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.154999_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/972073","article-title":"Inflammatory cytokine profile associated with metabolic syndrome in adult patients with type 1 diabetes","volume":"2015","author":"Ferreira-Hermosillo","year":"2015","journal-title":"J. Diab. Res."},{"issue":"2","key":"10.1016\/j.cyto.2020.154999_b0025","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/biof.1459","article-title":"Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome","volume":"45","author":"Darroudi","year":"2019","journal-title":"BioFactors"},{"key":"10.1016\/j.cyto.2020.154999_b0035","first-page":"1","article-title":"Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature","author":"Di Marco","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.cyto.2020.154999_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1494-4","article-title":"T-cell senescence contributes to abnormal glucose homeostasis in humans and mice","volume":"10","author":"Yi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2020.154999_b0045","article-title":"Cell populations and functions are altered in human obesity and type 2 diabetes","author":"Touch","year":"2017179","journal-title":"Curr. Diab. Rep."},{"issue":"6","key":"10.1016\/j.cyto.2020.154999_b0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-004-1403-x","article-title":"Interleukin-6 and tumor necrosis factor-? are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness","volume":"47","author":"Carey","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2005.04.019","article-title":"Interferon-$\u03b3$ and atherosclerosis: pro-or anti-atherogenic?","volume":"67","author":"Harvey","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0060","article-title":"Plasma cytokines and risk of coronary heart disease in the PROCARDIS study","volume":"5","author":"Clarke","year":"2018","journal-title":"Open Hear."},{"issue":"9","key":"10.1016\/j.cyto.2020.154999_b0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/apm.12246","article-title":"Effect of serum interleukin 21 on the development of coronary artery disease","volume":"122","author":"Ding","year":"2014","journal-title":"Apmis"},{"issue":"16","key":"10.1016\/j.cyto.2020.154999_b0070","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","article-title":"Interleukin (IL)-10 inhibits nuclear factor B (NFB) activation in human monocytes IL-10 and IL-4 suppress cytokine synthesis by different mechanisms","volume":"270","author":"Wang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4199","article-title":"TNF-\u03b1 blockade induces IL-10 expression in human CD4+ T cells","volume":"5","author":"Evans","year":"2014","journal-title":"Nat. Commun"},{"issue":"12","key":"10.1016\/j.cyto.2020.154999_b0080","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/ATVBAHA.114.304636","article-title":"T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans","volume":"34","author":"McLaughlin","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.cyto.2020.154999_b0085","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/diacare.28.8.2036","article-title":"Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals","volume":"28","author":"Straczkowski","year":"2005","journal-title":"Diab. Care [Internet]."},{"key":"10.1016\/j.cyto.2020.154999_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep21244","article-title":"Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes","volume":"6","author":"Barry","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2020.154999_b0095","doi-asserted-by":"crossref","unstructured":"L.Q. Jiang, N. Franck, B. Egan, R.J.O. Sj\u00f6gren, M. Katayama, D. Duque-guimaraes, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7 2019, pp. 1359\u20131366.","DOI":"10.1152\/ajpendo.00236.2013"},{"key":"10.1016\/j.cyto.2020.154999_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7209872","article-title":"Serum Levels of Interleukin-13 increase in subjects with insulin resistance but do not correlate with markers of low-grade systemic inflammation","volume":"2018","author":"Mart\u00ednez-Reyes","year":"2018","journal-title":"J. Diab. Res."},{"issue":"7","key":"10.1016\/j.cyto.2020.154999_b0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/CIRCULATIONAHA.116.025760","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus","volume":"135","author":"Saito","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cyto.2020.154999_b0115","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.154999_b0120","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1152\/ajpendo.90617.2008","article-title":"Evaluating the glucose tolerance test in mice","author":"Andrikopoulos","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2020.154999_b0125","doi-asserted-by":"crossref","unstructured":"J.S. Lehmann, A. Zhao, B. Sun, W. Jiang, S. Ji, Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform. 2017;(November):1\u201310.","DOI":"10.3791\/56440-v"},{"issue":"12","key":"10.1016\/j.cyto.2020.154999_b0130","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/dc18-1289","article-title":"Increased prevalence of type 2 diabetes-related complications in combined type 2 diabetes and sickle cell trait","volume":"41","author":"Skinner","year":"2018","journal-title":"Diab. Care"},{"issue":"3","key":"10.1016\/j.cyto.2020.154999_b0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.cyto.2020.154999_b0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2020.154999_b0145","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1\u03b2 and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/oby.21243","article-title":"Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNF\u03b1 production","volume":"24","author":"Ip","year":"2016","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.cyto.2020.154999_b0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.179.3.1449","article-title":"TNF-\u03b1 drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses","volume":"179","author":"Iwamoto","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.154999_b0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2009.05.012","article-title":"Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose","volume":"31","author":"Saraiva","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cyto.2020.154999_b0165","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V97.6.1742","article-title":"Selective inhibition of interleukin-4 gene expression in human T cells by aspirin","volume":"97","author":"Cianferoni","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2020.154999_b0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor \u03b1 and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cyto.2020.154999_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11803-y","article-title":"IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation","volume":"7","author":"Mitchell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2020.154999_b0180","unstructured":"Lindsay M. Coe JDD, LRM. Low dose aspirin therapy decreases blood glucose levels but does not prevent Type I, 2011;48824(517)."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:15Z","timestamp":1760907315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":35,"alternative-id":["S1043466620300156"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154999","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL\/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metformin","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.154999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154999"}}